依普黄酮 T0309
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 35212-22-7 | ¥418.00 | 询底价 |
5 g | 35212-22-7 | ¥587.00 | 询底价 |
1 g | 35212-22-7 | ¥460.00 | 询底价 |
500 mg | 35212-22-7 | ¥333.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Ipriflavone
描述: Ipriflavone (Osteofix) 是一种合成异黄酮衍生物,可用于抑制骨吸收。
细胞实验: Cells are exposed to various concentrations of Ipriflavone for 24, 48, 72 and 96 hours. Cells are treated with trypan blue to estimate the number of viable cells. For thymidine incorporation analysis, [3H]Thymidine (1 μCi) is added, and cells are harvested onto glass fiber filters 4 hours later. Radioactivity is determined by scintillation counting.(Only for Reference)
体外活性: Ipriflavone可以明显抑制MDA-231异种移植的肿瘤生长,与对照组小鼠相比,治疗后的小鼠体积分别减少25%和45%,重量分别减少47%和63%,并延长荷瘤小鼠的寿命.对于骨转移癌,口服给药12 mg Ipriflavone明显抑制MDA-231细胞的新溶骨骨转移的发展,抑制溶骨性病变的进展,并减少临近癌细胞的破骨细胞数量.
体内活性: 通过增强某些重要基质蛋白的表达并促进矿化过程,Ipriflavone调节人骨髓基质骨祖细胞(BMC)的分化和生物合成。在培养的小鼠未分化骨细胞中,10 mM Ipriflavone明显抑制糖基化终产物增强的骨吸收。Ipriflavone在50 mM剂量下不会引起MDA-231细胞的凋亡。Ipriflavone剂量依赖性抑制MDA-231细胞的增殖和DNA合成,并阻断配体诱导的EGFR中Tyr845的磷酸化。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: Ethanol : 2 mg/mL (7.13 mM)
DMSO : 60 mg/mL (214.04 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)
关键字: Inhibitor | inhibit | Ipriflavone
相关产品: FPS-ZM1 | 4'-Methoxyresveratrol | Azeliragon
相关库: Anti-Aging Compound Library | Drug Repurposing Compound Library | ReFRAME Related Library | Drug-Fragment Library | Bioactive Compounds Library Max | Inhibitor Library | Orally Active Compound Library | Featured Novel Bioactive Compound Library | NO PAINS Compound Library | Bioactive Compound Library
依普黄酮 T0309信息由TargetMol中国为您提供,如您想了解更多关于依普黄酮 T0309报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途